Evergreen Capital Management LLC Novartis Ag Transaction History

Evergreen Capital Management LLC

$2.6 Billion
Q2 2024

A detailed history of Evergreen Capital Management LLC transactions in Novartis Ag stock. As of the latest transaction made, Evergreen Capital Management LLC holds 14,424 shares of NVS stock, worth $1.67 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

14,424

Previous 14,692 1.82%

Holding current value

$1.67 Million

Previous $1.42 Million 8.02%

% of portfolio

0.06%

Previous 0.06%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$92.57 - $107.37 $24,808 - $28,775	-268 Reduced 1.82%	14,424 $1.54 Million
Q1 2024 May 15, 2024	BUY	$95.27 - $108.47 $111,656 - $127,126	1,172 Added 8.67%	14,692 $1.42 Million
Q4 2023 Feb 14, 2024	BUY	$92.27 - $101.54 $5,167 - $5,686	56 Added 0.42%	13,520 $1.37 Million
Q3 2023 Nov 14, 2023	BUY	$94.73 - $105.13 $20,935 - $23,233	221 Added 1.67%	13,464 $1.37 Million
Q2 2023 Aug 14, 2023	BUY	$92.52 - $104.91 $142,018 - $161,036	1,535 Added 13.11%	13,243 $1.34 Million
Q1 2023 May 15, 2023	SELL	$80.03 - $92.81 $147,335 - $170,863	-1,841 Reduced 13.59%	11,708 $1.08 Million
Q4 2022 Feb 14, 2023	SELL	$75.55 - $92.52 $75 - $92	-1 Reduced 0.01%	13,549 $1.23 Million
Q3 2022 Nov 14, 2022	BUY	$74.61 - $87.26 $236,439 - $276,526	3,169 Added 30.53%	13,550 $1.03 Million
Q2 2022 Aug 15, 2022	BUY	$80.52 - $93.75 $106,930 - $124,500	1,328 Added 14.67%	10,381 $877,000
Q1 2022 May 16, 2022	BUY	$80.11 - $90.62 $155,092 - $175,440	1,936 Added 27.2%	9,053 $794,000
Q4 2021 Mar 11, 2022	BUY	$79.7 - $88.13 $94,364 - $104,345	1,184 Added 19.96%	7,117 $623,000
Q3 2021 Nov 15, 2021	BUY	$81.78 - $95.14 $17,255 - $20,074	211 Added 3.69%	5,933 $485,000
Q2 2021 Aug 16, 2021	BUY	$85.24 - $94.15 $117,034 - $129,267	1,373 Added 31.57%	5,722 $522,000
Q1 2021 May 17, 2021	SELL	$83.5 - $98.47 $70,223 - $82,813	-841 Reduced 16.2%	4,349 $372,000
Q4 2020 Feb 16, 2021	BUY	$78.07 - $94.43 $56,991 - $68,933	730 Added 16.37%	5,190 $490,000
Q3 2020 Nov 16, 2020	BUY	$82.14 - $91.0 $6,242 - $6,916	76 Added 1.73%	4,460 $388,000
Q2 2020 Aug 14, 2020	SELL	$80.93 - $91.1 $198,197 - $223,103	-2,449 Reduced 35.84%	4,384 $383,000
Q1 2020 May 15, 2020	SELL	$70.67 - $99.01 $357,731 - $501,188	-5,062 Reduced 42.56%	6,833 $563,000
Q4 2019 Feb 14, 2020	BUY	$84.35 - $95.37 $27,160 - $30,709	322 Added 2.78%	11,895 $1.13 Million
Q3 2019 Nov 14, 2019	BUY	$85.54 - $94.26 $50,981 - $56,178	596 Added 5.43%	11,573 $1.01 Million
Q2 2019 Aug 14, 2019	BUY	$75.4 - $92.8 $74,495 - $91,686	988 Added 9.89%	10,977 $1 Million
Q1 2019 May 10, 2019	BUY	$75.32 - $86.15 $21,089 - $24,122	280 Added 2.88%	9,989 $960,000
Q4 2018 Feb 14, 2019	BUY	$73.66 - $82.02 $20,624 - $22,965	280 Added 2.97%	9,709 $833,000
Q3 2018 Nov 13, 2018	BUY	$66.94 - $77.43 $28,650 - $33,140	428 Added 4.76%	9,429 $812,000
Q2 2018 Aug 13, 2018	SELL	$64.91 - $73.36 $649 - $733	-10 Reduced 0.11%	9,001 $680,000
Q1 2018 May 10, 2018	BUY	$70.39 - $84.15 $634,284 - $758,275	9,011 New	9,011 $729,000

Others Institutions Holding NVS

# of Institutions

1,426

Shares Held

138M

Call Options Held

1.48M

Put Options Held

1.54M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $249B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Evergreen Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Evergreen Capital Management LLC with notifications on news.

Account

Evergreen Capital Management LLC Novartis Ag Transaction History